ALPRAZolam Extended Release Oral Tablet [Xanax]
RxNorm 687021
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 687021 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ALPRAZolam Extended Release Oral Tablet [Xanax].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ALPRAZolam Extended Release Oral Tablet [Xanax]
(Atom ID: 6376367)
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Alprazolam Extended Release Oral Tablet [Xanax]
(Atom ID: 12322671)
Patient Education
Alprazolam
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.